GLOBAL POLYMERASE CHAIN REACTION MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL POLYMERASE CHAIN REACTION MARKET FORECAST 2019-2027

GLOBAL POLYMERASE CHAIN REACTION MARKET FORECAST 2019-2027

The polymerase chain reaction is the technique that produces several replicas of a target DNA region in vitro. The method depends on a DNA polymerase, which is thermostable and known as TAQ polymerase. This polymerase is obtained from the Thermus aquaticus. They live in hydrothermal vents and hot springs. The PCR reaction involves repeat cycles through a series of temperatures, which yields many copies of the target region to be replicated. Globally, the market of polymerase chain reaction contributed $XX million in 2018 and is anticipated to create $13,644 million by the end of 2027. The market is expected to showcase a CAGR of 6.19% during the projecting period from 2019 to 2027. For the market study, 2018 is taken into account as the base year, whereas the anticipated period lies between 2019 and 2027.

GLOBAL POLYMERASE CHAIN REACTION MARKET FORECAST 2019-2027

Global Polymerase Chain Reaction Market by Technology (Real-time Pcr, Traditional Pcr, Digital Pcr) by Product (Reagent and Consumables, Instruments, Software, Services) by Application (Clinical, Research, Forensics) by End-user (Diagnostic Centers & Hospitals, Biotech & Pharma Companies, Academic and Research Institutes) by Geography.

Request free sample

The polymerase chain reaction is the technique that produces several replicas of a target DNA region in vitro. The method depends on a DNA polymerase, which is thermostable and known as TAQ polymerase. This polymerase is obtained from the Thermus aquaticus. They live in hydrothermal vents and hot springs. The PCR reaction involves repeat cycles through a series of temperatures, which yields many copies of the target region to be replicated. Globally, the market of polymerase chain reaction contributed $XX million in 2018 and is anticipated to create $13,644 million by the end of 2027. The market is expected to showcase a CAGR of 6.19% during the projecting period from 2019 to 2027. For the market study, 2018 is taken into account as the base year, whereas the anticipated period lies between 2019 and 2027.

The key factors that are responsible for the global polymerase chain reaction market advancement are:

  • Reagents and consumables hold the largest market share
  • Rise in infectious diseases worldwide
  • Increasing demand for digital PCR (d-PCR)

To know more about this report, request a free sample copy.

The global polymerase chain reaction market growth is majorly influenced by the growing elderly populace, along with the increasing incidences of infectious diseases. The rapid advancements in technology, together with growing investments of the chief companies in the techniques, are other influencing factors that boost the market growth. The advent of newer PCR techniques will be leading to a shorter throughput time and an increased sensitivity, which is further fuels the growth of the polymerase chain reaction market during the forecast period.

In 2018, the academic and research institutes in the polymerase chain reaction market accounted for the largest share of 46.91% in the end-user segment. The segment for academic and research institutes is primarily driven by the increasing initiatives of research activities coupled with the revolution of products is driving the growth of this segment in the forecast period. Growth in the strategic initiatives by the company, coupled with the demand for personalized medicine, has further boosted the growth of the company.

In total, the rising trend for personalized medicine is also showcasing growth projections for this segment. During the projected years from 2019 to 2027, the polymerase chain reaction market growth is also influenced by the growing investments in drug discovery and genomics.

Though the polymerase chain reaction techniques are largely accepted across the globe, the market also faces restraints and challenges. One of the major factors inhibiting market growth is the incapability of the conventional PCR technique to target complex endpoint sequences. Another major challenge posed to the market is the presence of alternate technologies for DNA sequencing. Moreover, market growth worldwide is further hindered due to the high cost of labor and instruments.

Report scope of the global polymerase chain reaction market encompasses segmentation based on technology, product, end-user, application and region.

Market by Technology:

  • Digital PCR
  • Traditional PCR
  • Real-Time PCR

Market by Product:

  • Reagents and Consumables
  • Instruments
  • Software
  • Services

Market by Application:           

  • Clinical
  • Research
  • Forensics

Market by End-User:

  • Diagnostic Centers & Hospitals
  • Biotech & Pharma Companies
  • Academic & Research Institutions

Geographically, the global polymerase chain reaction market has been segmented on the basis of four major regions, which are:

  • North America: The United States & Canada
  • Europe: France, United Kingdom, Spain, Germany, Italy, & Rest of Europe
  • Asia Pacific: Australia, China, Japan, India, South Korea, & Rest of Asia Pacific
  • Rest of World: Latin America, Middle East & Africa.

In terms of revenue, North America region leads in the polymerase chain reaction market, with around 41% market share in 2018. In North America, there is the presence of several renowned companies that offer these services in this region, which contributes to the dominance of the region in the polymerase chain reaction market. The well-established players are, namely Hoffman La Roche Ltd. (U.S.), Agilent Technologies Inc. (U.S), and many more.

Further, the North America polymerase chain reaction market is enlarging owing to many factors like the rising diseases such as hepatitis, cancer, and HIV/AIDS along with the rising research and development activities undertaken by biotechnological & pharmaceutical firms in this region. The Centers for Disease Control and Prevention (CDC) states that, $XX million people in the United States are affected by HIV. In addition, the market of polymerase chain reaction in North America is growing because of the rising use of the PCRs in laboratories together with the development of new products in this region.

The Asia Pacific region showcases the fastest-growing market during the forecast period. The fastest growth rate of Asia Pacific is attributed to many factors, such as the rising prevalence of infectious diseases increase in R&D investments and stiff competition by the market players. These factors uplift the growth in emerging economies of India, China, Japan, and Thailand.

Bio Rad Laboratories Inc. has launched first of its kind RT-PCR Systems, which features facial verification, voice instructions, radio-frequency identification (RFID)-plate scanning, and access to service and support. This will further boost the polymerase chain reaction market. Also, the increasing collaborations and mergers between key players for launching innovative products with more efficient polymerase chain reaction techniques will further fuel the market growth in the future.

Global polymerase chain reaction market has been segmented by technology, product, end-user, and application. The end-user segments include academic & research institutions, diagnostic centers & hospitals, and biotech & pharma companies. Product type comprises reagents & consumables, software, instruments, and services. The application segment comprises clinical, research, and forensics.

The market has the presence of a number of players, and some of the prominent players involved in the global polymerase chain reaction market are:

  • Agilent Technologies Inc.
  • F. Hoffman La Roche Ltd.
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.
  • Others

The company profiles of prominent market players are discussed in detail. Most of the companies, in order to gain a competitive edge over each other, are seeking corporate strategies such as partnership, merger & acquisition, contracts, new product launch, and agreements. For instance, in April 2019, Agilent launched a system that brands quality control in next-generation sequencing easier, faster, and economical. This development will reduce the time taken to carry out a sequencing generation faster.

Key findings of the global polymerase chain reaction market:

  • North America leads the global polymerase chain reaction market by capturing the largest market share of around 41% in 2018
  • The focus of market players is to pace up the R&D capabilities coupled with the innovation of new products
  • Asia Pacific global polymerase chain reaction market is anticipated to grow at the highest CAGR of XX% during the forecast period of 2019-2027
  • Growth in the trend of the increasing prevalence of infectious diseases worldwide
  • The demand for digital PCR systems is boosting the growth of the market in the forecast period 2019-2027
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • REAGENTS AND CONSUMABLES HOLDS THE LARGEST MARKET SHARE
      • RISE IN INFECTIOUS DISEASES WORLDWIDE
      • INCREASING DEMAND FOR DIGITAL PCR
  1. MARKET DYNAMICS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • RISING INCIDENCES OF INFECTIONS AND DISEASES
      • DEVELOPMENT IN PHARMACOGENOMICS
      • EMERGENCE OF DIGITAL PCR
      • INCREASING PUBLIC-PRIVATE INVESTMENTS AND GRANTS
    • MARKET RESTRAINTS
      • NON-VALIDATED HOME BREW TESTS
      • HIGH DEVICE COSTS ASSOCIATED WITH PCR
      • NECESSITY OF TRAINING AND UPDATION OF LABORATORIES WORKERS
    • MARKET OPPORTUNITIES
      • RISE IN FUNDING OF GENE AND HUMAN GENOME PROJECTS
      • EXPANDING HEALTHCARE MARKET IN APAC
    • MARKET CHALLENGES
      • INACCURACY CAUSED BY THE PCR TECHNIQUES
      • INCREASING AVAILABILITY OF ALTERNATIVE TECHNOLOGIES
  1. MARKET BY TECHNOLOGY
    • REAL-TIME PCR
    • TRADITIONAL PCR
    • DIGITAL PCR
  2. MARKET BY PRODUCT
    • REAGENT AND CONSUMABLES
    • INSTRUMENTS
    • SOFTWARE
    • SERVICES
  3. MARKET BY APPLICATION
    • CLINICAL
    • RESEARCH
    • FORENSICS
  4. MARKET BY END-USER
    • DIAGNOSTIC CENTERS & HOSPITALS
    • BIOTECH & PHARMA COMPANIES
    • ACADEMIC AND RESEARCH INSTITUTES
  5. KEY ANALYTICS
    • PORTER’S FIVE FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF COMPETITIVE RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
  6. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • UNITED STATES
      • CANADA
    • EUROPE
      • UNITED KINGDOM
      • GERMANY
      • FRANCE
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC
      • CHINA
      • JAPAN
      • INDIA
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • COMPANY PROFILES
      • AGILENT TECHNOLOGIES INC.
      • BIORAD TECHNOLOGIES INC.
      • QIAGEN N.V.
      • HOFFMAN LA ROCHE LTD.
      • THERMOFISHER SCIENTIFIC INC.
      • ABBOTT LABORATORIES
      • BECTON DICKINSON BIOSCIENCES SYSTEMS AND REAGENTS INC.
      • SIEMENS HEALTHINEERS
      • BIOMERIEUX SA
      • DANAHER CORPORATION
      • MDXHEALTH CORPORATION
      • NANO BIOSYS INC.
      • TAHARA BIO INC.
      • FLUIDIGM CORPORATION
      • PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

 

LIST OF TABLES

TABLE 1. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY GEOGRAPHY, 2019-2027 (IN $ MILLION)

TABLE 2. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)

TABLE 3. GLOBAL PCR MARKET, BY REAL-TIME PCR, 2019-2027 (IN $ MILLION)

TABLE 4. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)

TABLE 5. GLOBAL REAGENT AND CONSUMABLES MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 6. GLOBAL INSTRUMENTS MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 7. GLOBAL SOFTWARE MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 8. GLOBAL SERVICES MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 9. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY APPLICATION, 2019-2027 (IN $ MILLION)

TABLE 10. GLOBAL CLINICAL MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 11. GLOBAL RESEARCH MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 12. GLOBAL FORENSICS MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 13. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY END USER 2019-2027 (IN $ MILLION)

TABLE 14. GLOBAL DIAGNOSTIC CENTERS & HOSPITALS MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 15. GLOBAL BIOTECH AND PHARMA COMPANIES MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 16. GLOBAL ACADEMIC AND RESEARCH INSTITUTES MARKET, BY REGION, 2019-2027 (IN $ MILLION)

TABLE 17. OPPORTUNITY MATRIX

TABLE 18. VENDOR LANDSCAPE

TABLE 19. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY GEOGRAPHY, 2019-2027 (IN $ MILLION)

TABLE 20. NORTH AMERICA POLYMERASE CHAIN REACTION (PCR) MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 21. EUROPE POLYMERASE CHAIN REACTION (PCR) MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 22. ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)

TABLE 23. REST OF WORLD POLYMERASE CHAIN REACTION (PCR) MARKET, BY REGION, 2019-2027 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TYPE, 2018 & 2027 (IN %)

FIGURE 2. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY REAL-TIME PCR, 2019-2027 (IN $ MILLION)

FIGURE 3. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY TRADITIONAL PCR, 2019-2027 (IN $ MILLION)

FIGURE 4. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY REAGENTS AND CONSUMABLES, 2019-2027 (IN $ MILLION)

FIGURE 5. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY INSTRUMENTS, 2019-2027 (IN $ MILLION)

FIGURE 6. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY SOFTWARE, 2019-2027 (IN $ MILLION)

FIGURE 7. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY SERVICES, 2019-2027 (IN $ MILLION)

FIGURE 8. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY CLINICAL, 2019-2027 (IN $ MILLION)

FIGURE 9. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY RESEARCH, 2019-2027 (IN $ MILLION)

FIGURE 10. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY FORENSICS, 2019-2027 (IN $ MILLION)

FIGURE 11. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY DIAGNOSTIC CENTERS & HOSPITALS, 2019-2027 (IN $ MILLION)

FIGURE 12. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY BIOTECH & PHARMA COMPANIES, 2019-2027 (IN $ MILLION)

FIGURE 13. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, BY ACADEMIC & RESEARCH INSTITUTES, 2019-2027 (IN $ MILLION)

FIGURE 14. PORTER’S FIVE FORCE ANALYSIS

FIGURE 15. GLOBAL POLYMERASE CHAIN REACTION (PCR) MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)

FIGURE 16. UNITED STATES POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 17. CANADA POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 18. UNITED KINGDOM POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 19. GERMANY POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 20. FRANCE POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 21. SPAIN POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 22. ITALY POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 23. REST OF EUROPE POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 24. CHINA POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 25. JAPAN POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 26. INDIA POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 27. SOUTH KOREA POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 28. AUSTRALIA POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 29. REST OF ASIA PACIFIC POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 30. LATIN AMERICA POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

FIGURE 31. MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION (PCR) MARKET, 2019-2027 (IN $ MILLION)

  1. MARKET BY TECHNOLOGY
    • REAL-TIME PCR
    • TRADITIONAL PCR
    • DIGITAL PCR
  2. MARKET BY PRODUCT
    • REAGENT AND CONSUMABLES
    • INSTRUMENTS
    • SOFTWARE
    • SERVICES
  3. MARKET BY APPLICATION
    • CLINICAL
    • RESEARCH
    • FORENSICS
  4. MARKET BY END-USER
    • DIAGNOSTIC CENTERS & HOSPITALS
    • BIOTECH & PHARMA COMPANIES
    • ACADEMIC AND RESEARCH INSTITUTES
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • UNITED STATES
      • CANADA
    • EUROPE
      • UNITED KINGDOM
      • GERMANY
      • FRANCE
      • SPAIN
      • ITALY
      • REST OF EUROPE
    • ASIA PACIFIC
      • CHINA
      • JAPAN
      • INDIA
      • SOUTH KOREA
      • AUSTRALIA
      • REST OF ASIA PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now